These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 35290461)

  • 21. Therapeutic efficacy of artemether-lumefantrine on treatment of uncomplicated Plasmodium falciparum mono-infection in an area of high malaria transmission in Zambia.
    Hamainza B; Masaninga F; Moonga H; Mwenda M; Chanda-kapata P; Chalwe V; Chanda E; Kamuliwo M; Babaniyi OA
    Malar J; 2014 Nov; 13():430. PubMed ID: 25403945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artesunate-amodiaquine and artemether-lumefantrine for the treatment of uncomplicated falciparum malaria in Liberia: in vivo efficacy and frequency of molecular markers.
    Koko VS; Warsame M; Vonhm B; Jeuronlon MK; Menard D; Ma L; Taweh F; Tehmeh L; Nyansaiye P; Pratt OJ; Parwon S; Kamara P; Asinya M; Kollie A; Ringwald P
    Malar J; 2022 Apr; 21(1):134. PubMed ID: 35477399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of a substantial number of sub-microscopic Plasmodium falciparum infections by polymerase chain reaction: a potential threat to malaria control and diagnosis in Ethiopia.
    Golassa L; Enweji N; Erko B; Aseffa A; Swedberg G
    Malar J; 2013 Oct; 12():352. PubMed ID: 24090230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effectiveness and safety of artesunate-amodiaquine versus artemether-lumefantrine for home-based treatment of uncomplicated Plasmodium falciparum malaria among children 6-120 months in Yaoundé, Cameroon: a randomized trial.
    Niba PTN; Nji AM; Ali IM; Akam LF; Dongmo CH; Chedjou JPK; Fomboh CT; Nana WD; Oben OLA; Selly-Ngaloumo AA; Moyeh MN; Ngu JA; Ludovic AJ; Aboh PM; Ambani MCE; Omgba PAM; Kotcholi GB; Adzemye LM; Nna DRA; Douanla A; Ango Z; Ewane MS; Ticha JT; Tatah FM; Dinza G; Ndikum VN; Fosah DA; Bigoga JD; Alifrangis M; Mbacham WF
    BMC Infect Dis; 2022 Feb; 22(1):166. PubMed ID: 35189818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should countries implementing an artemisinin-based combination malaria treatment policy also introduce rapid diagnostic tests?
    Zikusooka CM; McIntyre D; Barnes KI
    Malar J; 2008 Sep; 7():176. PubMed ID: 18793410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Asymptomatic Plasmodium falciparum infection is associated with anaemia in pregnancy and can be more cost-effectively detected by rapid diagnostic test than by microscopy in Kinshasa, Democratic Republic of the Congo.
    Matangila JR; Lufuluabo J; Ibalanky AL; Inocêncio da Luz RA; Lutumba P; Van Geertruyden JP
    Malar J; 2014 Apr; 13():132. PubMed ID: 24690179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atovaquone-proguanil for treating uncomplicated Plasmodium falciparum malaria.
    Blanshard A; Hine P
    Cochrane Database Syst Rev; 2021 Jan; 1(1):CD004529. PubMed ID: 33459345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyronaridine-artesunate and artemether-lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children: a randomized controlled non-inferiority trial.
    Roth JM; Sawa P; Makio N; Omweri G; Osoti V; Okach S; Choy F; Schallig HDFH; Mens P
    Malar J; 2018 May; 17(1):199. PubMed ID: 29764419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive malaria treatment among school-aged children in sub-Saharan Africa: a systematic review and meta-analyses.
    Cohee LM; Opondo C; Clarke SE; Halliday KE; Cano J; Shipper AG; Barger-Kamate B; Djimde A; Diarra S; Dokras A; Kamya MR; Lutumba P; Ly AB; Nankabirwa JI; Njagi JK; Maiga H; Maiteki-Sebuguzi C; Matangila J; Okello G; Rohner F; Roschnik N; Rouhani S; Sissoko MS; Staedke SG; Thera MA; Turner EL; Van Geertruyden JP; Zimmerman MB; Jukes MCH; Brooker SJ; Allen E; Laufer MK; Chico RM
    Lancet Glob Health; 2020 Dec; 8(12):e1499-e1511. PubMed ID: 33222799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo/ex vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine as first-line treatment for uncomplicated falciparum malaria in children: an open label randomized controlled trial in Burkina Faso.
    Lingani M; Bonkian LN; Yerbanga I; Kazienga A; Valéa I; Sorgho H; Ouédraogo JB; Mens PF; Schallig HDFH; Ravinetto R; d'Alessandro U; Tinto H
    Malar J; 2020 Jan; 19(1):8. PubMed ID: 31906948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasmodium malariae after successful treatment of P. falciparum malaria with artemether-lumefantrine.
    Tournoy TK; Rosanas-Urgell A; Van Esbroeck M; Bottieau E; Huits R
    Int J Infect Dis; 2022 Jun; 119():56-58. PubMed ID: 35358721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of combining intermittent preventive treatment with home management of malaria in children less than 10 years in a rural area of Senegal: a cluster randomized trial.
    Tine RC; Faye B; Ndour CT; Ndiaye JL; Ndiaye M; Bassene C; Magnussen P; Bygbjerg IC; Sylla K; Ndour JD; Gaye O
    Malar J; 2011 Dec; 10():358. PubMed ID: 22166001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Schistosoma haematobium effects on Plasmodium falciparum infection modified by soil-transmitted helminths in school-age children living in rural areas of Gabon.
    Dejon-Agobé JC; Zinsou JF; Honkpehedji YJ; Ateba-Ngoa U; Edoa JR; Adegbite BR; Mombo-Ngoma G; Agnandji ST; Ramharter M; Kremsner PG; Lell B; Grobusch MP; Adegnika AA
    PLoS Negl Trop Dis; 2018 Aug; 12(8):e0006663. PubMed ID: 30080853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disparities of Plasmodium falciparum infection, malaria-related morbidity and access to malaria prevention and treatment among school-aged children: a national cross-sectional survey in Côte d'Ivoire.
    Houngbedji CA; N'Dri PB; Hürlimann E; Yapi RB; Silué KD; Soro G; Koudou BG; Acka CA; Assi SB; Vounatsou P; N'Goran EK; Fantodji A; Utzinger J; Raso G
    Malar J; 2015 Jan; 14():7. PubMed ID: 25559587
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania.
    Mhamilawa LE; Wikström S; Mmbando BP; Ngasala B; Mårtensson A
    Malar J; 2020 Jul; 19(1):250. PubMed ID: 32664948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmodium falciparum community prevalence and health-seeking behaviours in rural Sussundenga District, Mozambique.
    Earland DE; Bibe AF; Novela A; Ferrão J; Searle KM
    Malar J; 2022 Oct; 21(1):305. PubMed ID: 36307833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High prevalence of Plasmodium falciparum gametocyte infections in school-age children using molecular detection: patterns and predictors of risk from a cross-sectional study in southern Malawi.
    Coalson JE; Walldorf JA; Cohee LM; Ismail MD; Mathanga D; Cordy RJ; Marti M; Taylor TE; Seydel KB; Laufer MK; Wilson ML
    Malar J; 2016 Nov; 15(1):527. PubMed ID: 27809907
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The risk of Plasmodium vivax parasitaemia after P. falciparum malaria: An individual patient data meta-analysis from the WorldWide Antimalarial Resistance Network.
    Hossain MS; Commons RJ; Douglas NM; Thriemer K; Alemayehu BH; Amaratunga C; Anvikar AR; Ashley EA; Asih PBS; Carrara VI; Lon C; D'Alessandro U; Davis TME; Dondorp AM; Edstein MD; Fairhurst RM; Ferreira MU; Hwang J; Janssens B; Karunajeewa H; Kiechel JR; Ladeia-Andrade S; Laman M; Mayxay M; McGready R; Moore BR; Mueller I; Newton PN; Thuy-Nhien NT; Noedl H; Nosten F; Phyo AP; Poespoprodjo JR; Saunders DL; Smithuis F; Spring MD; Stepniewska K; Suon S; Suputtamongkol Y; Syafruddin D; Tran HT; Valecha N; Van Herp M; Van Vugt M; White NJ; Guerin PJ; Simpson JA; Price RN
    PLoS Med; 2020 Nov; 17(11):e1003393. PubMed ID: 33211712
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine.
    Straimer J; Gandhi P; Renner KC; Schmitt EK
    J Infect Dis; 2022 Apr; 225(8):1411-1414. PubMed ID: 34216470
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The duration of chemoprophylaxis against malaria after treatment with artesunate-amodiaquine and artemether-lumefantrine and the effects of pfmdr1 86Y and pfcrt 76T: a meta-analysis of individual patient data.
    Bretscher MT; Dahal P; Griffin J; Stepniewska K; Bassat Q; Baudin E; D'Alessandro U; Djimde AA; Dorsey G; Espié E; Fofana B; González R; Juma E; Karema C; Lasry E; Lell B; Lima N; Menéndez C; Mombo-Ngoma G; Moreira C; Nikiema F; Ouédraogo JB; Staedke SG; Tinto H; Valea I; Yeka A; Ghani AC; Guerin PJ; Okell LC
    BMC Med; 2020 Feb; 18(1):47. PubMed ID: 32098634
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.